AstraZeneca Plc has announced plans to make 22 compounds available to medical researchers in the UK free of charge in a bid to promote more drug discovery. The compounds are not the focus of current research at the company. ---Subscribe to MedNous to access this article--- Research & University News Regulation & Policy
